Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine

This page shows you your search results in order of relevance. This is page number 17.

Order by Relevance | Date

Total 2327 results found since Jan 2013.

Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment
Expert Rev Anti Infect Ther. 2021 Apr 14. doi: 10.1080/14787210.2021.1917992. Online ahead of print.ABSTRACTINTRODUCTION: Acyclovir has led to the development of successful systemic therapy for herpes simplex virus and varicella-zoster virus (VZV) infection, and the use of valacyclovir and famciclovir has improved treatment. Additionally, the use of a helicase-primase (HP) inhibitor (HPI), amenamevir, is changing the treatment of herpes zoster (HZ).AREA COVERED: VZV infection is prevented by vaccines and is treated with antiviral agents. Acyclovir and penciclovir are phosphorylated by viral thymidine kinase and work as cha...
Source: Expert Review of Anti-Infective Therapy - April 15, 2021 Category: Infectious Diseases Authors: Kimiyasu Shiraki Masaya Takemoto Tohru Daikoku Source Type: research

The incidence of herpes zoster in patients with diabetes mellitus: A meta-analysis of cohort studies
The research has correlated the risk factors of herpes zoster with some chronic diseases. This meta-analysis aimed to assess the incidence of herpes zoster in patients with diabetes mellitus. We conducted a literature search using Web of Science and PubMed for articles published from January 1, 2000 to December 31, 2019. The incidence rate ratio and 95% confidence interval for herpes zoster associated with diabetes mellitus was calculated. We included 5 cohort studies for a meta-analysis. The pooled incidences of herpes zoster in patients with diabetes mellitus and in patients without diabetes mellitus were 7.22 and ...
Source: Medicine - April 23, 2021 Category: Internal Medicine Tags: Research Article: Meta-Analysis of Observational Studies in Epidemiology Source Type: research

Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland
Conclusions: UVV appears highly effective and cost-effective when compared with current clinical practice and recommendations in Switzerland from both a direct medical costs perspective and societal perspective.
Source: The Pediatric Infectious Disease Journal - May 21, 2021 Category: Infectious Diseases Tags: Original Studies Source Type: research

An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine
ConclusionThis review of spontaneously reported post-marketing data did not raise safety concerns regarding the occurrence of vesicular and bullous cutaneous eruptions following vaccination with RZV.
Source: Drug Safety - October 7, 2021 Category: Drugs & Pharmacology Source Type: research

Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies
ConclusionRoutine adult vaccinations are associated with a significant reduction in dementia risk and may be an effective strategy for dementia prevention. Further research is needed to elucidate the causal effects of this association and the underlying mechanisms.
Source: Frontiers in Immunology - May 3, 2022 Category: Allergy & Immunology Source Type: research

Neuro-Ophthalmological Complications of the COVID-19 Vaccines: A Systematic Review
Conclusion: Since the implementation of the COVID-19 vaccination campaign in the past year, several post-COVID-vaccination neuro-ophthalmological complications have been described. However, considering the number of individuals that have been exposed to the vaccines, the risk seems very low, and the clinical outcome in most cases is favorable. Therefore, on a population level, the benefits of the vaccines far outweigh the risk of neuro-ophthalmological complications.
Source: Journal of Neuro-Ophthalmology - May 27, 2022 Category: Opthalmology Tags: Disease of the Year 2021 Encore: COVID-19 Source Type: research

Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65  years: a systematic review
AbstractThis systematic review aims to summarize the impact of vaccination against influenza, shingles, and pneumococcus on the incidence on the risk of cardiovascular events in the elderly. This protocol was developed in accordance with PRISMA guidelines. We conducted a literature search and identified all relevant articles published regarding the matter up to September 2022. We retrieved 38 studies (influenza vaccine  = 33, pneumococcal vaccine = 5, and zoster vaccine = 2). A total of 28 and 2 studies have shown that influenza and pneumococcal vaccines significantly lower the risk of cardiovascular disease ...
Source: AGE - June 3, 2023 Category: Geriatrics Source Type: research

What Immunizations Can Pregnant and Postpartum Women Receive?
Discussion Pregnant, postpartum and breastfeeding women along with their infants are at higher risk for infectious diseases. Pregnant women have altered immune, cardiac and respiratory systems that contribute to the increased risk. It is thought that postpartum immunological recovery can be up to 1 year. For the infant, breastfeeding provides some immunity to infectious diseases. Cocooning, where others in close contact are immunized against common infectious diseases is also another strategy to help infants who are not yet old enough to be vaccinated. Recent guidelines for treatment of influenza with antiviral medication...
Source: PediatricEducation.org - October 27, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news